Nephrilin™ is a revolutionary new medical intervention for kidney disease. By inhibiting a key mechanism underlying kidney failure, this medicine could potentially save the healthcare system billions of dollars by delaying the need for dialysis in people with diabetes. Recent research at Ontherix™ has revealed a basic imbalance in the way cells communicate which could account for kidney failure, the spread of human cancer and a variety of other human disease processes. By correcting that imbalance, these disease processes might be reduced or prevented. Nephrilin™has shown efficacy in animal models of diabetic nephropathy (kidney disease). Another Ontherix™product in development is Ontherine™, which dramatically sensitizes breast cancer and leukemia cells to existing conventional treatments without a corresponding effect on normal cells in the body.